The innovative drug sector is active. Zhongheng Group and Laimei Pharmaceuticals rose and stopped, while Onlikang, Xidian Pharmaceuticals, Weill Pharmaceuticals, Haizheng Pharmaceuticals, and BeiGene Shenzhou followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.